MedPath

Effect of processed oil in nasal instillation for allergic response

Phase 2
Registration Number
CTRI/2023/11/060092
Lead Sponsor
KAHER Post Graduate Research Grant
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Any Gender, Caste, Economical class individuals.

2.Individuals who have had allergic episodes in the previous 6 months.

3.TNSS Score of more than 6 out of 12.

Exclusion Criteria

1.Known cases of Lung damage, Chronic Rhinitis, atrophic rhinitis, Rhinosinusitis.

2.Diagnosed cases of Infective diseases like Tuberculosis, Pneumonia.

3.Known Cases of Systemic disorders like uncontrolled diabetes mellitus, Hypertension (not on medication).

4.Individuals on regular anti-allergic medications.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
asal Instillation of Anu Taila reduces the IgE and AEC Levels.Timepoint: Reduction in IgE, AEC titer levels after 30 days of intervention.
Secondary Outcome Measures
NameTimeMethod
Reduction in Clinical Allergic Symptoms Measured by TNSS ScoreTimepoint: After 30 days of Nasal Instillation of 8 Bindu Anu taila everyday in each nostril, There will be reduction in TNSS.
© Copyright 2025. All Rights Reserved by MedPath